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Morphological assessment of the retina in
uveitis
Michael M. Altaweel1,9*, Sapna S. Gangaputra1, Jennifer E. Thorne2,3, James P. Dunn10, Susan G. Elner4, Glenn J. Jaffe5,
Rosa Y. Kim6, P. Kumar Rao7, Susan B. Reed1, John H. Kempen8 and on behalf of the MUST Research Group
Abstract
Background: The objective of this study is to describe a system for color photograph evaluation in uveitis and
report baseline morphologic findings for the Multicenter Uveitis Steroid Treatment (MUST) Trial.
Four-hundred seventy-nine eyes of 255 subjects with intermediate, posterior, and panuveitis had stereoscopic color
fundus photographs obtained by certified photographers and evaluated by certified graders using standardized
procedures to evaluate morphologic characteristics of uveitis. The posterior pole was evaluated for macular edema,
vitreoretinal interface abnormalities, and macular pigment disturbance/atrophy; the optic disk was assessed for
edema, pallor, or glaucomatous changes. The presence of neovascularization, vascular occlusion, vascular sheathing,
and tractional retinal changes was determined. A random subset of 77 images was re-graded to determine the
percentage agreement with the original grading on a categorical scale.
Results: At baseline, 437/479 eyes had images available to grade. Fifty-three eyes were completely ungradable due
to media opacity. Common features of intermediate and posterior/panuveitis were epiretinal membrane (134 eyes,
35 %), and chorioretinal lesions (140 eyes, 36 %). Macular edema was seen in 16 %. Optic nerve head and vascular
abnormalities were rare. Reproducibility evaluation found exact agreement for the presence of chorioretinal lesions
was 78 %, the presence and location of macular edema was 71 %, and the presence of epiretinal membrane was
71 %. Vertical cup-to-disk ratio measurement had intra-class correlation of 0.75.
Conclusions: The MUST system for evaluating stereoscopic color fundus photographs describes the morphology of
uveitis and its sequelae, in a standardized manner, is highly reproducible, and allows monitoring of treatment effect
and safety evaluation regarding these outcomes in clinical trials.
Background
The Multicenter Uveitis Steroid Treatment (MUST)
Trial is a randomized, partially masked, multicenter clin-
ical trial comparing the effectiveness and safety of local
therapy with the fluocinolone acetonide implant (Bausch
& Lomb, Inc.) versus standardized systemic therapy with
oral corticosteroids supplemented by immunosuppres-
sive drugs when indicated for patients with severe non-
infectious intermediate uveitis, posterior uveitis, or
panuveitis [1].
The MUST Trial required standardized, masked evalu-
ation of color fundus photographs of the eyes with uve-
itis among the patients enrolled in the study across
multiple clinical centers to reliably assess the structural
complications of intraocular inflammation and the mor-
phological effects of treatment. This report describes the
MUST Trial methodology for independent assessment
of stereoscopic color photographs by the University of
Wisconsin Fundus Photograph Reading Center (RC),
provides data on the reproducibility of the evaluation
procedures, and reports the baseline color fundus
photograph-derived morphologic findings of the trial
cohort.* Correspondence: mmaltaweel@wisc.edu
1Fundus Photograph Reading Center, Department of Ophthalmology and
Visual Sciences, University of Wisconsin-Madison, Madison, USA
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Methods
Study participants
The study was conducted at 23 clinical sites in the USA,
the United Kingdom, and Australia. The protocol and
informed consent forms are compliant with the Declar-
ation of Helsinki and were implemented under the ap-
proval of the institutional review boards governing the
participating centers. Prior to the participation in the
study, all clinical centers completed certification of the
imaging system and certification of the participating
photographer(s) through the Fundus Photograph Read-
ing Center, Department of Ophthalmology and Visual
Sciences at the University of Wisconsin-Madison. Pa-
tients were randomized on a 1:1 basis to one of the two
treatment groups. Patients were imaged at baseline and
study specified visits with de-identified photographs sent
to the reading center for evaluation. Two-hundred fifty-
five subjects were enrolled in this study; 479 eyes had
uveitis at baseline. Of these, 437 eyes had gradable im-
ages. This report concentrates on the morphologic fea-
tures of the evaluable eyes with uveitis at baseline.
Image acquisition procedure
All patients underwent pharmacologic pupil dilation
followed by three-field modified stereoscopic photog-
raphy using 30° or 35° field with specified capture and
export settings. The photographic fields include field
1M, where the image is centered on the temporal edge
of the optic disk, field 2—centered on the macula, and
field 3M—centered temporal to the center of the macula
(Fig. 1). The fields have been modified from the standard
Early Treatment Diabetic Retinopathy Study (ETDRS)
photographic protocol [2] in order to provide additional
views of the macula. At every visit, stereoscopic red re-
flex images were taken to document media opacities.
Images were obtained in film format and sent as color
slides or were obtained digitally with certified cameras
and saved on a CD or DVD uncompressed and submit-
ted to the RC according to standard procedures.
Photo quality assessment
Film sets were viewed upon a standard light box (6500°K
color temperature), using a Donaldson stereo viewer
(×5). Digital images were displayed upon calibrated 20.5′
′ LCD monitors and were viewed with hand-held stereo
viewers (Screen-Vu Stereoscope, PS Mfg. Co., Portland,
OR). Optimum image illumination, contrast, and color
balance for the digital images were achieved by a stan-
dardized procedure at the RC [3] where the luminance
histograms for each of the red/green/blue (RGB) color
channels were analyzed and manually adjusted to en-
hance color contrast and standardize illumination.
Quality of both film and digital images was rated by
the graders based upon the ability of the grader to view
and grade different lesions of uveitis. The photographs
were graded as good if image quality allowed a clear
view of the retina and borderline when visibility was
moderate and some features could not be graded due to
quality issues such as poor stereo, poor focus, or inad-
equate field definition. Images were considered ungrad-
able if there was either a very poor view or no view of
the fundus.
Ungradable images were reviewed by image quality ex-
perts; on occasions where images have poor quality due
to photographic technique, the clinics were contacted
and photographer education and retraining were con-
ducted. When poor image quality was due to patient-
related factors such as media opacity (cataract or media
haze) or confounding abnormality, the reason was
documented.
Grading procedures
Ocular disease evaluators at the reading center are
trained extensively to assess and quantify lesions associ-
ated with intraocular inflammation. A certification exam
is required prior to evaluation of study images, and on-
going quality control is conducted with retraining when
indicated, in order to maintain a high level of quality of
the data generated. Images are graded longitudinally: in
grading follow-up images, the grader has access to previ-
ous images and can use the information in the decision-
making for the current visit being graded. This approach
allows notable changes in morphology to be identified,
particularly those considered to be safety related. In
grading color photographs, graders do not have access
Fig. 1 The anatomic location of the three photographic fields
imaged to study the posterior pole
Altaweel et al. Journal of Ophthalmic Inflammation and Infection  (2016) 6:33 Page 2 of 11
to other imaging modalities (fluorescein angiograms or
optical coherence tomograms (OCT)) taken for the same
subject. Evaluators are masked to treatment assignment
to remove bias in morphologic assessment.
The primary objective of the MUST Trial was to com-
pare the relative effectiveness of systemic corticosteroids
plus immunosuppression versus intraocular fluocinolone
acetonide implant for treatment of non-infectious inter-
mediate, posterior, or panuveitis. The grading of color
photographs was designed to permit all possible presen-
tations of intermediate and posterior or panuveitis to be
captured in a satisfactory manner and also to allow
evaluation of changes in morphology over time.
The grading form was developed at the Fundus Photo-
graph Reading Center, Madison, WI (Additional file 1),
and is a modification of ETDRS diabetic retinopathy
evaluation [2], with the addition of questions specific to
the assessment of retinal and choroidal inflammation.
This grading procedure has been used in numerous
clinical trials and has shown good to excellent reprodu-
cibility for assessment of vascular lesions and macular
edema. Evaluation questions for the types of chorioret-
inal lesions were drafted to be descriptive and not diag-
nostic due to the lack of consensus on the classification
of various posterior uveitides.
Optic nerve head abnormalities
Papillary swelling may be associated with ocular inflam-
mation. Severity of blurring of the optic disk margins is
assessed by percentage involvement, as demonstrated in
an ETDRS standard photograph with 270° of disk mar-
gin edema (Fig. 2). Chronic inflammation may lead to
loss of optic nerve fibers and optic atrophy, character-
ized by optic nerve pallor (Fig. 3). Another important as-
pect of optic nerve morphology is the evaluation of optic
nerve head cup-to-disk ratio (CDR). This may increase
over time in the eyes with sustained elevation of
intraocular pressure (which was expected to occur fre-
quently in the trial). CDR is assessed by evaluating the
vertical diameter of the optic disk margin and optic cup,
using anatomic landmarks and stereoscopic photography
to identify boundaries [4] (Fig. 4). Notching of the neu-
roretinal rim and disk hemorrhages are evaluated as
additional morphologic features that may represent pro-
gressive damage of the optic nerve head due to elevated
intraocular pressure.
Macular edema
Macular edema is a frequently noted structural compli-
cation in the eyes with uveitis and is associated with loss
of visual acuity [5–7]. The assessment of macular edema
Fig. 2 ETDRS standard photograph [2] (ETDRS example photograph
C) demonstrating an optic nerve head with papillary swelling
affecting 270° of the margin (from 2 o’clock to 5 o’clock)
Fig. 3 Image showing an optic nerve head with pallor. Note the
constricted retinal arterioles, ghost vessels, and chorioretinal lesions
Fig. 4 Image demonstrating the measurement of vertical cup and
disk diameter in order to calculate cup-to-disk ratio
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requires good stereoscopic color imaging and is per-
formed according to the procedure described for dia-
betic retinopathy in ETDRS Report 10 [2]. The ETDRS
grid, with a size of 16 disk areas, is centered on the
fovea, and the region within the grid is assessed for ret-
inal thickening. The area involved is reported in disk
areas and is determined by summing the percentage in-
volvement within each subfield of the grid. Proximity of
retinal thickening to the center of the macula and sever-
ity of thickening are assessed. For digital images, cus-
tomized electronic measurement tools in Topcon
IMAGEnet systems (Paramus, NJ) are used for evaluat-
ing the presence and extent of macular edema within 16
DA of the foveal center. In addition to retinal thicken-
ing, color images are graded for the presence of cystoid
spaces. An important confounding factor that limits the
utility of grading macular edema from color photographs
in uveitis is the frequent presence of vitreoretinal inter-
face abnormalities, such as epiretinal membrane. The
appearance of retinal surface pathology makes it difficult
to distinguish underlying edema and therefore precludes
assessment for edema in these eyes. Grading presence
and extent of macular edema in the MUST trial was
more reliably accomplished with optical coherence tom-
ography and fluorescein angiography [8].
Vitreoretinal interface abnormalities
Structural complications of the vitreoretinal interface are
frequently noted sequelae of intermediate, posterior, and
panuveitis. Cellophane reflex denotes a shiny appearance
of the macula, is not associated with retinal traction, and
is unlikely to affect visual acuity. Epiretinal membranes
have more evident depth, may obscure underlying retinal
detail, may be associated with retinal striae, and can be
associated with tractional forces that contribute to
macular edema or (in extreme cases) tractional retinal
detachment (Fig. 5). Preretinal neovascularization and
subsequent fibrosis are potential sequelae of chronic
uveitis that can be associated with significant traction
upon the retina. These complications are evaluated for
their presence or absence and their effect upon the mac-
ula (see Additional file 1 for detailed grading questions).
Chorioretinal lesions
An important component in the diagnosis of posterior
or panuveitis and in the evaluation of severity and pro-
gression is the assessment of chorioretinal lesions. The
characteristic lesions identified in the grading program
are described as follows (see Fig. 6):
1. Punched-out lesions—lesions are deep, appear punched
out, and may be surrounded by pigmentation. This
appearance is commonly noted in multifocal
choroiditis [9] and also can occur in presumed ocular
histoplasmosis [10] (not studied in the MUST Trial).
2. Multiple hypopigmented round-oval lesions—multi-
ple, shallow, cream-colored, or depigmented round
or oval spots with indistinct margins, characteristic-
ally seen in birdshot chorioretinitis [11, 12].
3. Placoid lesions—flat, gray-white lesions with irregu-
lar patchy distribution present at the level of the ret-
inal pigment epithelium (RPE), classically observed
with acute posterior multifocal placoid pigment
epitheliopathy (APMPPE) [13, 14].
4. Serpiginoid lesions—typically begin adjacent to the
optic disk and spread peripherally in a serpentine
manner with profound retinal pigment epithelial
atrophy. There usually will be hyperpigmentation at
the edge of the lesions [15, 16]. There may be
satellite lesions.
5. Other chorioretinal lesions—lesions that do not fit
well in the prior categories are termed “other”
lesions. This may include scars, RPE
hyperpigmentation or atrophy, or subretinal fibrosis.
Fig. 5 The left panel shows an epiretinal membrane in the macular region, and the right panel shows an epiretinal membrane inducing traction
leading to distortion of the macula
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Lesion activity is graded on color photos. Active le-
sions generally exhibit blurred lesion margins, an ap-
pearance which contrasts sharply with inactive lesions
that have sharply defined borders often with associated
pigmentation (Fig. 7).
For all chorioretinal lesions, longitudinal grading is
conducted for notable changes from baseline. An in-
crease in the number of lesions, growth in area of
lesions, evidence of activity, or new involvement of the
fovea are identified.
Retinal vascular abnormalities
Retinal vascular assessment includes grading of features
consistent with uveitis or subsequent complications. Ret-
inal vessels are assessed for sheathing (sometimes a sign
of activity) and sclerosis (Fig. 8). Sheathing is distinguished
Fig. 6 Specific subtypes of inflammatory chorioretinal lesions
Fig. 7 The left panel shows an active lesion with blurry ill-defined margins, while the right panel shows well-demarcated and pigmented
inactive lesions
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from sclerosis as a yellowish appearance external to the
vessel wall rather than narrowing of the vessel caliber.
Hemorrhages may be preretinal, subretinal, or retinal and
may be associated with chorioretinal lesions or with neo-
vascularization. Hemorrhages and neovascularization are
assessed as described by ETDRS Report 10 [2]. Vascular
occlusive disease may occur in the setting of uveitis; fea-
tures of retinal venous or arterial occlusion are graded and
identified as notable changes from baseline.
Reproducibility of color photograph evaluation
Quality control of MUST grading was performed by re-
peat grading of a random set of 77 images. For the vari-
ous graded features, the calculated measures of
agreement included the percent agreement (exact agree-
ment and agreement within one step), kappa statistic (k),
and weighted k statistic. Weighted k values were com-
puted by assigning a weight of 1 for perfect agreement,
0.75 for one-step disagreement, and 0 for all other dis-
agreements. Landis and Koch’s benchmarks [17] were
used to evaluate simple and weighted k statistics in
which k in the ranges of <0.00, 0.00–0.20, 0.21–0.40,
0.41–0.60, 0.61–0.80, 0.81–1.00, respectively, correspond
to poor, slight, fair, moderate, substantial, and almost
perfect agreement.
Results
Two-hundred fifty-five subjects were enrolled at 23 clin-
ical sites with images obtained when possible on the 479
eyes with uveitis at baseline. Of these, 437 eyes (243 sub-
jects) had color photographs taken and were included in
this analysis. Three-hundred three eyes had images ac-
quired on film and 134 using native digital images.
Among these images, 53 eyes (12 %) had poor quality
which rendered all variables ungradable; thus, 88 % of
eyes were imaged sufficiently well to allow assessment of
the eye using this approach. The primary outcome of the
MUST Trial was change in best-corrected visual acuity
from baseline to 2 years. It is important to note that the
ability to obtain retinal images was not an eligibility cri-
terion for the MUST Trial in order to allow inclusion of
patients with advanced and severe uveitis who would be
appropriate candidates for the alternative treatments in
the study. The primary reason for poor image quality
was poor ocular media, due to small pupils (extensive
posterior synechiae), lens opacity, and/or vitreous haze.
Infrequently, image quality was poor due to photog-
rapher technique (5 %) or camera artifact.
Among the eyes assessed, optic nerve abnormalities
were rare. Papillary swelling was found in 17 eyes (5 %)
and optic nerve pallor in 8 eyes (2 %). Disk hemorrhages
were noted in 2 eyes and notching of the rim of the
optic nerve head (ONH) was found in 2 eyes. Vertical
CDR was not measureable in 20 eyes (6 %), either due to
poor stereoscopic view of the optic cup or confounding
abnormalities on the optic nerve head. Among the eyes
with measureable CDR, both the mean and median CDR
was 0.3.
Assessment of the macula for macular edema was not
possible in 154 of the eyes that were imaged successfully
(35 %). Inability to grade was due to poor photo quality
(101 eyes) or the presence of confounding abnormalities
(53 eyes)—primarily the presence of an epiretinal mem-
brane (ERM) which prevents the grader from clearly
identifying whether the underlying retina is edematous
on color photos. Among the 283 eyes assessed for
Fig. 8 Retinal vascular changes found in the posterior segment uveitis
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macular edema, definite macular edema within the
ETDRS grid was found in 44 eyes (16 %), with 42 eyes
having edema or cysts that affected the center of the
macula. ERM was gradable in 384 eyes. Cellophane re-
flex was noted in 48 eyes (13 %), subtle ERM in 93 eyes
(24 %), and obvious ERM in 41 eyes (11 %). Traction
due to epiretinal membrane was noted in 66 eyes (17 %),
the most common appearance being that of striae in the
retina. Distorted vessels, dragged macula due to traction,
and retinal detachment were rare.
Subretinal abnormalities such as choroidal neovas-
cularization, fibrosis, and subretinal exudation were
infrequent. Chorioretinal lesions were identified in
140 of the 384 evaluable eyes (36 %). A single eye
could have more than one type of chorioretinal le-
sion. The lesions fit the description of punched-out
lesions in 32 eyes, multiple hypopigmented round-
oval lesions in 59 eyes, placoid lesions in 12 eyes, and
serpiginoid in 24 eyes. In addition, there were 81 eyes
that had chorioretinal lesions that were not catego-
rized into one of the lesion types described above,
most commonly scars and hyperpigmented lesions.
Forty-two eyes had chorioretinal lesions considered
active. Retinal neovascularization and vitreous and
preretinal hemorrhages were not seen in this cohort
at baseline.
Table 1 presents the comparison of replicate grading
(n = 77 eyes) with the original grading. Agreement for
the presence and location of chorioretinal lesions was
substantial, with 60 eyes (78 %) in exact agreement with
original grade and 70 eyes (91 %) within one step (sim-
ple k = 0.62 (95 % CI 0.48–0.67) and weighted k (wk) =
0.73 (95 % CI 0.60–0.87). Macular edema agreement was
assessed by evaluating the presence and location of
macular edema. Fifty-five eyes (71 %) were in exact
agreement (wk = 0.69, 95 % CI 0.55–0.83) and 69 eyes
(90 %, wk = 0.69, 95 % CI 0.55–0.83) were within one
step. Agreement regarding the height of retinal thicken-
ing at the center of the macula had exact agreement in
59 eyes (77 %; wk = 0.71, 95 % CI 0.57 = 0.85) and within
one step in 68 eyes (88 %). A large proportion of the
eyes randomly selected for reproducibility had epiretinal
membrane. The agreement for the presence and type of
epiretinal membrane was substantial, with 55 eyes
(71 %) in exact agreement and 71 eyes (92 %, wk = 0.78,
95 % CI 0.67–0.88) within one step (Fig. 9).
The most important variable from optic nerve head
assessment included in the quality control analysis was
Table 1 Repeat evaluation of 77 eyes as compared to the original grade of record for the assessment of key features in evaluation
of color photographs for uveitis
Variable Exact agreement, number of
eyes (%)
Within one step, number of
eyes (%)
Kappa (95 % CI) wKappa (95 % CI)
Presence and extent of chorioretinal lesionsa 60 (78 %) 70 (90.9 %) 0.62 (0.48, 0.76) 0.73 (0.60, 0.87)
Presence of retinal thickeningb 55 (71 %) 69 (89.6 %) 0.54 (0.40, 0.69) 0.69 (0.55, 0.83)
Retinal thickening at centerc 59 (77 %) 68 (88.3 %) 0.60 (0.46, 0.75) 0.71 (0.57, 0.85)
Presence and type of epiretinal membraned 55 (71 %) 71 (92.2 %) 0.62 (0.48, 0.75) 0.78 (0.67, 0.88)
CI confidence interval
aPresence and location of chorioretinal lesions:
0—Absent
1—Questionable
2—Definite, anywhere
3—Definite, within ETDRS grid
4—Definite, at center point of the fovea
8—Cannot grade
bPresence of retinal thickening:
0—absent
1—questionable
2—definite, outside ETDRS grid
3—definite, within ETDRS grid
8—cannot grade
cRetinal thickening as center of macula:
0—absent
1—questionable
2—definite, <1× reference
3—definite, <2× reference
4—definite, >2× reference
8—cannot grade
dEpiretinal membrane:
0—absent
1—questionable
2—cellophane reflex
3—definite, subtle
4—definite, obvious
8—cannot grade
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the vertical CDR, an important safety outcome in a steroid
treatment trial. CDR was analyzed as a continuous vari-
able and assessed using intraclass correlation (ICC). Verti-
cal CDR measurement had intra-class correlation of 0.75.
Discussion
The MUST Trial compared management of intermedi-
ate, posterior, and panuveitis with fluocinolone implant
versus systemic therapy with steroid and immunosup-
pressive medications. The spectrum of noninfectious
uveitides encompassed within the trial was broad, with
significant heterogeneity in morphological appearance at
baseline. Fundus photographs are critical in document-
ing the anatomic lesions associated with uveitis. Com-
bined with history, clinical examination, and laboratory
results, retinal findings can provide adequate data to
classify the uveitic entity. The Standardization of Uveitis
Nomenclature working group has recommended that
fundus photographs or fluorescein angiograms are re-
quired as evidence for reporting structural complications
of uveitis in epidemiological trials, clinical trials, and
clinical reports [18]. The Wisconsin Fundus Photograph
Reading Center developed protocols which provide stan-
dardized evaluation of these anatomic features and out-
comes. In the MUST Trial, clinicians are not masked to
treatment assignment and hence have the potential to be
biased in their assessment, and therefore RC grading of
photographs is advantageous for masked objective evalu-
ation of outcome measures. Such morphological assess-
ment provides evidence of the structural effects of
chronic uveitis, treatment response, and adverse events.
Posterior and panuveitides encompass several diseases
which have different presentations and course of progres-
sion such that different management is required for each
type of uveitis. For example, CMV retinitis presents with
large areas of necrotizing retinitis that progresses swiftly,
requiring immediate initiation of antiviral treatment,
APMPPE presents with diffuse placoid lesions that are self
limiting, and Birdshot chorioretinopathy presents with
multiple depigmented lesions that require prompt im-
munosuppression. In epidemiological studies, where the
focus is on the determination of type of uveitis and its nat-
ural history, the RC methodology and classification of ana-
tomic lesions would be very useful. In therapeutic clinical
trials, precise morphological characterization is also im-
portant to determine efficacy and complications of the
disease. In the MUST Trial, such characterization demon-
strated that the study groups were similar at baseline and
serves as a method to compare the efficacy and risks of
treatment between the two treatment groups.
Evaluation of the morphological features at baseline
among this cohort of the eyes demonstrated a high
prevalence of visually important complications of uveitis,
including macular edema and vitreoretinal interface ab-
normalities. Assessment of chorioretinal lesions showed
that although a third of the eyes had presence of lesions,
involvement of the fovea was uncommon (7 eyes). CDR
was within the normal range (median 0.3), and vascular
lesions were rare at baseline. The high rate of ungrad-
able photos in the MUST Trial was due to media opacity
such as vitreous haze due to uveitis activity, cataract,
and pupillary adhesions. The inclusion of eyes with ad-
vanced stages of severe uveitis presented a challenge to
reading center grading of morphologic characteristics. In
contrast, if a uveitis trial enrolls eyes that have less
severe uveitis at baseline, the proportion with successful
imaging and grading would be higher. In trials that
have morphologic endpoints as the primary outcome,
inclusion of eyes can be predicated on adequate
image quality.
Fig. 9 Intraclass correlation between the cup-to-disk ratio assessment in the original grade of record and the repeat quality control assessment
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Among those cases that could be imaged and graded,
morphological findings at baseline and through follow-
up may prove useful in explaining differential response
to treatment over time. If an eye has a significant epiret-
inal membrane and macular edema, the edema may be
less likely to resolve with treatment than in eyes with
macular edema but no vitreoretinal interface abnormal-
ity. Epiretinal membrane was present in 31 % of eyes at
baseline. Eyes with central chorioretinal lesions would
be limited in the potential to improve visual acuity des-
pite resolution of uveitis. Such examples demonstrate
the utility of accurately and thoroughly characterizing
the eyes enrolled in a therapeutic trial.
The Standardization of Uveitis Nomenclature (SUN)
working group [18] has advocated classifying uveitis
broadly by anatomic location (anterior, intermediate,
posterior, or panuveitis). Presently, there is no standard-
ized system for the description and classification of most
individual uveitic entities, resulting in ambiguity in the
reporting of clinical data and poor comparability of clin-
ical studies in the literature. The MUST Trial provides
an opportunity to study the clinical characteristics and
ocular complications of a large sample of eyes. Evalu-
ation of stereoscopic retinal images at a reading center
provides a uniform methodology for describing retinal
lesions and changes in morphology over time that re-
duces the variability inherent with clinician observers in
a multicenter trial.
Previous reports in uveitis literature include population-
based prevalence studies [19–24] and retrospective studies
on treatment modalities for uveitis. In most of these re-
ports, the primary outcome was improvement in clinically
determined inflammation as evidenced by the reduction
of inflammatory cells or by using corticosteroid-sparing
effect (reduction of prednisone dose to <10 mg/day) as a
surrogate for control of inflammation [25–35]. Further de-
tails of fundus pathology and changes with treatment were
not reported. Safety events characterized by changes in
morphology were not detailed in a uniform manner. Valu-
able information regarding the morphological features of
chronic uveitis and treatment effects could have been ob-
tained through systematic assessment of fundus photo-
graphs. This may have been useful in indicating
differential response to therapy in various subgroups as
well as for monitoring for incident adverse events. In each
study involving treatment with steroid implants, develop-
ment of glaucoma-requiring treatment was common, with
up to 40 % of the 0.59- and 2.1-mg fluocinolone dose
groups combined requiring incisional surgery. These trials
relied on clinician determination for the diagnosis of glau-
coma. The MUST Trial obtains CDR data from photo-
graphic grading in a serial manner that provides another
method of identifying morphological changes that may be
attributed to glaucoma [36]. This serves as an additional
safety measure for an expected side effect of intravitreal
steroid administration.
An important component in the development and val-
idation of a new methodology includes the reliability of
the data collected. Review of the quality control data
from the reading center shows an appropriate degree of
reproducibility. The grading program required extensive
grader training and certification. Standardization of the
grading procedure improves the quality of data collected.
Possible enhancements to the grading procedure may in-
clude integrated grading of color photos and fluorescein
angiograms for the evaluation of the activity and pro-
gression of chorioretinal lesions. It also may be useful to
integrate photographic and OCT findings in the evalu-
ation of macular edema and morphology affecting the
vitreoretinal interface. OCT is critical for grading macu-
lar edema as it provides a cross-sectional assessment of
the macula which is not hindered by vitreoretinal inter-
face abnormalities and moderate media opacities [37].
The strengths of the grading methodology are that it is
an objective method that is reproducible and allows as-
sessment while masked to treatment assignment. Limita-
tions of the fundus photographic grading include the
relatively small field of view captured with this protocol,
compared with the overall retina. Macular edema cannot
be easily graded with fundus photographs in a uveitis co-
hort as epiretinal membrane presence precludes the as-
sessment of underlying retinal thickness. The solution
for this in MUST was the reliance on OCT grading for
determining retinal thickness and morphology associated
with edema, such as cystoid spaces [37]. Patients in the
MUST Trial had substantial media opacities (vitreous
haze, cataract, keratitic precipitates, pupillary adhesions)
that limited the number of eyes that could be adequately
photographed. Despite these limitations, the MUST
study provides the largest repository of morphological
data obtained from a prospective uveitis clinical trial to
date, allowing improved correlation of baseline and
follow-up findings with other outcome measures such as
visual acuity and uveitis control.
Conclusions
In conclusion, the procedure for masked, centralized
evaluation of color photographs for uveitis provides
reproducible data on the characteristic lesions of inter-
mediate and posterior uveitis suitable for use in clinical
trials. The outcomes can be followed over time to evalu-
ate treatment effects and ocular complications.
Additional file
Additional file 1: The Detailed Grading methodolgy developed for
National Eye Institute Trials. (DOCX 160 kb)
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